Actively Recruiting
Evaluating Accelerated Deep Transcranial Magnetic Stimulation to Reduce Antipsychotic-Induced Weight Gain in Schizophrenia A Double-Blind, Randomized, Sham-Controlled Trial
Led by Second Xiangya Hospital of Central South University · Updated on 2026-10-27
60
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This trial studies patients with schizophrenia who have experienced weight gain due to antipsychotic medications. Researchers are evaluating the safety and effectiveness of accelerated deep transcranial magnetic stimulation a-dTMS to reduce this weight gain. The study also aims to build a model predicting treatment response and understand the mechanisms involved using brain imaging and metabolic analysis. Participants are randomly assigned to receive either active a-dTMS or a sham treatment. The active group will get accelerated intermittent theta burst stimulation three times daily for 10 consecutive days, with at least 50 minutes between sessions, alongside a symptom provocation task involving food craving. The sham group undergoes similar procedures without actual brain stimulation. Follow-up assessments occur at baseline, day 12, and day 42 post-treatment. Throughout the study, participants will have their body weight, BMI, eating behavior questionnaires, and brain activity measured using EEG-fMRI at rest and during tasks. Additional assessments include blood tests and cognitive tasks related to impulse control. These evaluations help researchers measure changes over time and monitor safety. The entire participation period lasts about six weeks from baseline through follow-up.
CONDITIONS
Brief Title
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
Research Team
P
PING SHAO
R
Renrong Wu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here